Puma Biotechnology (PBYI) EBIAT (2017 - 2025)
Historic EBIAT for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $8.8 million.
- Puma Biotechnology's EBIAT fell 5647.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 5931.33%. This contributed to the annual value of $30.3 million for FY2024, which is 4033.63% up from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's EBIAT is $8.8 million, which was down 5647.0% from $5.9 million recorded in Q2 2025.
- Over the past 5 years, Puma Biotechnology's EBIAT peaked at $20.3 million during Q3 2024, and registered a low of -$44.7 million during Q3 2021.
- Its 5-year average for EBIAT is $2.1 million, with a median of $3.0 million in 2025.
- As far as peak fluctuations go, Puma Biotechnology's EBIAT surged by 171000.0% in 2023, and later tumbled by 44368.31% in 2024.
- Puma Biotechnology's EBIAT (Quarter) stood at $4.2 million in 2021, then crashed by 232.72% to -$5.6 million in 2022, then skyrocketed by 318.84% to $12.3 million in 2023, then skyrocketed by 57.54% to $19.3 million in 2024, then crashed by 54.24% to $8.8 million in 2025.
- Its EBIAT stands at $8.8 million for Q3 2025, versus $5.9 million for Q2 2025 and $3.0 million for Q1 2025.